[HTML][HTML] Influences of genetic variants on stroke recovery: a meta-analysis of the 31,895 cases
Background The influences of genetic variants on functional clinical outcomes following
stroke are unclear. In order to reliably quantify these influences, we undertook a
comprehensive meta-analysis of outcomes after acute intracerebral haemorrhage (ICH) or
ischaemic stroke (AIS) in relation to different genetic variants. Methods PubMed, PsycInfo,
Embase and Medline electronic databases were searched up to January 2019. Outcomes,
defined as favourable or poor, were assessed by validated scales (Barthel index, modified�…
stroke are unclear. In order to reliably quantify these influences, we undertook a
comprehensive meta-analysis of outcomes after acute intracerebral haemorrhage (ICH) or
ischaemic stroke (AIS) in relation to different genetic variants. Methods PubMed, PsycInfo,
Embase and Medline electronic databases were searched up to January 2019. Outcomes,
defined as favourable or poor, were assessed by validated scales (Barthel index, modified�…
Background
The influences of genetic variants on functional clinical outcomes following stroke are unclear. In order to reliably quantify these influences, we undertook a comprehensive meta-analysis of outcomes after acute intracerebral haemorrhage (ICH) or ischaemic stroke (AIS) in relation to different genetic variants.
Methods
PubMed, PsycInfo, Embase and Medline electronic databases were searched up to January 2019. Outcomes, defined as favourable or poor, were assessed by validated scales (Barthel index, modified Rankin scale, Glasgow outcome scale and National Institutes of Health stroke scale).
Results
Ninety-two publications comprising 31,895 cases met our inclusion criteria. Poor outcome was observed in patients with ICH who possessed the APOE4 allele: OR =2.60 (95% CI = 1.25–5.41, p = 0.01) and in AIS patients with the GA or AA variant at the BDNF-196 locus: OR = 2.60 (95% CI = 1.25–5.41, p = 0.01) or a loss of function allele of CYP2C19: OR = 2.36 (95% CI = 1.56–3.55, p < 0.0001). Poor outcome was not associated with APOE4: OR = 1.02 (95% CI = 0.81–1.27, p = 0.90) or IL6-174 G/C: OR = 2.21 (95% CI = 0.55–8.86, p = 0.26) in patients with AIS.
Conclusions
We demonstrate that recovery of AIS was unfavourably associated with variants of BDNF and CYP2C19 genes whilst recovery of ICH was unfavourably associated with APOE4 gene.
Springer